Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 28,579 | 22,199 | 20,810 | 17,489 | 16,088 |
| Cost of Goods | 10,926 | 8,468 | 8,795 | 7,123 | 8,665 |
| Gross Profit | 17,653 | 13,731 | 12,015 | 10,366 | 7,423 |
| Operating Expenses | 29,430 | 26,711 | 26,435 | 23,586 | 23,078 |
| Operating Income | -10,851 | -12,512 | -13,625 | -13,097 | -14,990 |
| Interest Expense | 3 | 230 | 1,568 | 1,507 | 1,451 |
| Other Income | 1,659 | 339 | 1,415 | 1,392 | 836 |
| Pre-tax Income | -9,195 | -12,403 | -13,778 | -13,212 | -15,605 |
| Income Tax | -18 | 12 | 26 | N/A | 5 |
| Net Income Continuous | -9,177 | -12,415 | -13,804 | -13,212 | -15,610 |
| Net Income | $-9,177 | $-12,415 | $-13,804 | $-13,212 | $-15,610 |
| EPS Basic Total Ops | -0.24 | -0.35 | -0.40 | -0.42 | -0.55 |
| EPS Basic Continuous Ops | -0.24 | -0.35 | -0.40 | -0.42 | -0.56 |
| EPS Diluted Total Ops | -0.24 | -0.35 | -0.40 | -0.42 | -0.55 |
| EPS Diluted Continuous Ops | -0.24 | -0.35 | -0.40 | -0.42 | -0.56 |
| EBITDA(a) | $-11,509 | $-12,970 | $-14,149 | $-13,214 | $-14,668 |